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Abstract
In this report we present a method to cultivate Borrelia spirochetes from human serum samples
with high efficiency. This method incorporates improved sample collection, optimization of culture
media and use of matrix protein. The method was first optimized utilizing Borrelia laboratory
strains, and later by demonstrating growth of Borrelia from sera from fifty seropositive Lyme
disease patients followed by another cohort of 72 Lyme disease patients, all of whom satisfied the
strict CDC surveillance case definition for Lyme disease. The procedure resulted in positive
cultures in 47% at 6 days and 94% at week 16. Negative controls included 48 cases. The positive
identification of Borrelia was performed by immunostaining, PCR, and direct DNA sequencing.
Key words: Clinical microbiology, Vector-borne diseases, Lyme disease, Spirochetes.

Introduction
It has long been an elusive goal to develop a
successful in vitro culture method for wild-type,
pathogenic Borrelia. Multiple attempts using a variety
of methods have not been able to obtain a high yield
or keep them alive for an extended period of time [1]
[2]. A successful culture system would be highly
useful, especially in light of the recognized public
health impact of the pathogen Borrelia burgdorferi, the
causative agent of Lyme disease.
Lyme disease is a rapidly emerging infectious
disease in the United States [3]. In most cases of Lyme
disease, early detection and treatment with a course of
antibiotics results in a successful outcome [2], [4].
However, because the signs and symptoms of disseminated Lyme disease are shared with many other
diseases [5], and because currently recommended
diagnostic laboratory tests are not 100% sensitive,
many cases of Lyme disease go undiagnosed and untreated, putting an infected patient at risk for developing a debilitating long-term illness [1] [6]-[9]. The

current recommended standard for Lyme disease
testing employs an indirect 2-step serological assay
that detects host immune reactivity to the Lyme disease bacteria [1] [2] [5]. In a significant number of
cases the serologic assays are not sufficiently sensitive
or specific [1], [10]-[15] in part due to the presence of
immune suppressive and modulating agents transmitted by the tick and secreted by the Borrelia spirochete [13]-[15] and antigen-antibody complex formation [16]-[19]. Thus DNA-detection methods
(polymerase chain reaction or PCR) have been developed but the assay has less than optimal sensitivity
as the concentration of Borrelia spirochetes in blood,
plasma, or serum samples from Lyme disease patients
can be very low [1], [2], [20]-[23]. In addition, inhibitors of PCR have been demonstrated to exist in the
peripheral blood [24]. For technical reasons
false-positive PCRs remain a concern [22], [25].
Therefore, there is a need to improve methods to detect Borrelia infection in patients including methods to
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cultivate Borrelia from human blood, urine, or tissue
samples [26].
The Borrelia-specific Barbour-Stoenner-Kelly
media (BSK media) has been used to culture Borrelia
[27], but the sensitivity is suboptimal [1], [2], [10],
[28]-[30]. The reported sensitivities range from as low
as 5% to a maximum of 88% in skin samples but a
maximum of only 40-44% for peripheral blood samples [1], [10], [28]-[32]. Because of these difficulties,
Borrelia cultures until now have not been widely used.
We report an improved method to cultivate Borrelia from human blood samples with a success rate of
94 %. This culture method incorporates two-step
process that consists of a short-term starter culture
that is used to seed a long-term phase, each utilizing
different cultivation environments. Combining the
two phases allows for more rapid initial growth and
ultimately a higher yield than has previously been
reported. This highly sensitive and specific method to
detect live Borrelia cultivated from patient’s serum
will improve our ability to make the diagnosis in cases
in which serologic or PCR based assays are not informative. In addition, cultures have been maintained
for as long as eight months, offering the potential to
serve as a useful source of clinical isolates for further
study.
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Materials and Methods

study participant and HIPAA-compliant privacy
measures were maintained. All patients who participated in this study had not been exposed to antibiotics
for a minimum of 4 weeks prior to blood sample collection [33] [34]. Sera from 50 seropositive patients
were used to establish the culture media and conditions. After the cultivation parameters were established, sera from an additional 72 Lyme disease patients (26 males and 46 females ranging in age from 3
to 80 years with average of 42 years) were collected
between March 2011 and May 2012 and used to evaluate this culture method. All of these patients had a
clinical presentation consistent with Lyme disease
and their illness was confirmed by laboratory evidence of infection using the Center for Disease Control (CDC) recommended, 2-tiered serological method, thus they all satisfied the strict CDC surveillance
case definition for Lyme disease.
To determine the specificity of the test we collected serum from 48 healthy controls that had no
history of either tick-bites or Lyme disease (21 males
and 27 females ranging in age from 27 to 71 years with
an average of 43 years). Patients and controls were
selected from private medical practices from 15 different States (CA, AR, CT, NH, NJ, NY, MA, MD, MN,
OR, PA, TN, UT, VT). Samples were delivered to the
laboratory and cultures were initiated within 24-30
hours of collection.

Abbreviations/nomenclature

Culture protocol

Members of the Borrelia genus often referred to
as Borrelia burgdorferi sensu lato, Borrelia species, Borrelia spp, will be referred to in this study by the genus
name, Borrelia. When species of Borrelia are referred to
here, they will be indicated by the specific species
name.

Culture of established cell lines
Low passage isolates of two different Borrelia
burgdorferi strains, B31 (ATCC # 35210) and 297
(ATCC # 53899), Borrelia afzelii (ATCC # 51992), and
Borrelia garinii (ATCC # 51991) were obtained from
American Type Tissue Collection. Escherichia coli
DH5α strain was purchased from Life Technologies.
Borrelia strains were maintained in complete BSK-H
media, which includes 6% rabbit serum (complete
media from Sigma-Aldrich #B8291) at 34oC with 5%
CO2 and 100% humidity. Each new lot of complete
BSK-H media was tested in a reference strain culture
as a measure of quality assurance. Escherichia coli cells
were maintained in standard Luria Broth media
(Sigma) at 37oC in a shaking incubator.

Blood collection
Full informed consent was obtained from each

Blood samples (~30 ml /patient) were collected
in the following tubes: 9.0 ml peripheral blood in a
15.0 ml polypropylene Falcon tube containing 5 ml
BSK-H, two samples consisting of 9.0 ml peripheral
blood in 10.0 ml red top (no additive) Vacutainer tube,
or Vacutainer tubes containing EDTA (purple top).
Blood samples were transported to the laboratory
overnight at room temperature and upon receipt they
were allowed to sit undisturbed for several hours at
room temperature to allow serum separation. The
serum was divided into eight starter cultures for each
clinical sample and mixed with modified BSK-H media (mBSK-H) - four in the standard 15 ml glass tube
(13 ml final volume) and four in the small 2ml cryo
tubes (1.8 ml final volume) as summarized in Table 2.
Cultures were incubated at 34º C with 5% CO2 and
100% humidity. The lids of all culture tubes were
closed loosely to allow limited gas exchange between
the culture medium and the environment. Starter
cultures were harvested after 6 days and used for either immunocytochemical studies or to seed a
long-term culture. Long-term cultures were established by combining and directly transferring cells
and media from culture tubes to a Coplin jar with an
http://www.medsci.org
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additional 15 ml mBSK-H media (total volume of 34
ml), a 5 µg rifampicin disc (BD Scientific) and 2 collagen coated slides (Rat-tail type I; BD Scientific) and
maintained through 16 weeks at 34oC with 5% CO2
and 100% humidity. After 8 weeks, one slide was
checked under dark field microscopy and used for
polyclonal anti-Borrelia antibody detection analysis. If
the fluorescent antibody result was negative at 8
weeks of culture, another collagen coated slide was
placed in the Coplin jar and half of the culture media
(~17 ml) was replaced with fresh mBSK-H medium
and the culture was incubated for an additional 8
weeks.

Immunodetection with polyclonal and monoclonal antibodies
For detection of Borrelia using the polyclonal antibody, cells from the starter culture tubes (Table 1)
were centrifuged at 9,600xg for 10 minutes at room
temperature, washed with 1x PBS buffer, pH 7.4, and
centrifuged again at 9,600xg. The pellet was resuspended in 75 µl of 1x PBS buffer and spread on a microscope slide (SuperFrost+, Fischer Scientific). Cells
were fixed by incubating the slides in acetone for 10
minutes at -20 ºC. For collagen-coated slides, the cells
were washed twice with 1x PBS, fixed in ice-cold acetone:methanol (1:1) mixture for 10 minutes at -20 ºC,
dried for 10 minutes at room temperature in a laminar
air-flow hood, and further dried at 37º for 20 minutes.
100 µl of polyclonal antibody (PA-1-73005 polyclonal
FITC labeled anti-Borrelia burgdorferi antibody,
Thermo Scientific, diluted 1:50 in 1% BSA/1x PBS)
was added to the dried and fixed cells (300 µl for collagen-coated slides). For a negative control, the primary antibody was omitted and replaced with normal
rabbit serum. The slides were incubated at 37ºC in a
humidified chamber for 1 hour, washed with 1x PBS
for 5 minutes at room temperature, then rinsed twice
in double distilled water and allowed to dry in the
laminar air-flow hood for 10 minutes. The slides were
mounted with Vectashield mounting medium with
DAPI counterstain (Vector Labs) and images were
taken by fluorescent microscopy. Unless noted otherwise, microscopy was performed at 400x magnification using an Olympus BX40 fluorescent microscope with attached digital camera. An internal validation study for the specificity of the polyclonal antibody showed that it is able to recognize reference
cultures of Borrelia burgdorferi, Borrelia afzelii and Borrelia garinii, but not Escherichia coli or Treponema denticola (data not shown).
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Table 1. Summary of the positive Borrelia clinical samples
cultured in 15ml and 2ml tubes tubes/collection tubes. *
positive samples grown in small tubes only.
POSITIVE
CULTURES

CULTURE TUBES
15ml

2ml

1

+

-

2

-

+*

3

+

-

4

+

-

5

-

+*

6

+

-

7

+

+

8

+

+

9

-

+*

10

+

+

11

+

-

12

+

-

13

+

-

14

+

-

15

+

-

16

+

-

17

+

-

18

+

+

19

-

+*

20

+

-

21

-

+*

22

+

-

23

+

-

24

+

-

25

+

-

26

+

-

27

+

+

Total

22

10

Table 2. Description of the different culture environments
for short-term cultures. * = modified BSK-H (including 12 %
rabbit serum, 100 µg/ml of DTT and rifampicin as antibiotics). ICC=Immunocytochemistry, LTC=Long-term Culture.
Tube Tube
#
type

Volume of the
culture medium*

Seed source

Day 6
use

1

15 ml

11.0 ml

2.0 ml serum/BSK-H

ICC

2

15 ml

11.0 ml

2.0 ml serum/BSK-H

LTC

3

15 ml

11.5 ml

1.5 ml serum

LTC

4

15 ml

11.5 ml

1.5 ml serum

ICC

5

2 ml

1.4 ml

0.4 ml serum/BSK-H

ICC

6

2 ml

1.4 ml

0.4 ml serum/BSK-H

LTC

7

2 ml

1.6 ml

0.2 ml serum

LTC

8

2 ml

1.6 ml

0.2 ml serum

ICC

http://www.medsci.org
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For monoclonal antibody detection of Borrelia,
cells were collected and adhered to a microscope slide
as described for the polyclonal antibody protocol. The
cells were fixed by incubation in fresh 4% paraformaldehyde solution for 20 minutes at room temperature
followed by incubation in cold methanol for 20
minutes at -20 ºC. The cells were treated in 0.3% Triton X-100 solution for 15 minutes at 37 ºC, then
washed twice with 1x PBS, twice with double distilled
water, air dried for 10 minutes in a laminar air-flow
hood, and further dried at 37 ºC for 20 minutes. The
slides were blocked with 100 µl diluted normal goat
serum (5% in 1% BSA/1x PBS, Vector Labs) in a humidified chamber at 37 ºC for 20 minutes. The slides
were washed twice with 1x PBS, and twice with double distilled water. 100 µl of monoclonal antibody
(MA-1-7006, Thermo Scientific, raised against Bb, diluted 1:10 in 1% BSA/1x PBS) was added to each slide
and incubated in a humidified chamber at room
temperature overnight (~16h). For a negative control,
the monoclonal antibody was omitted and replaced
with normal mouse serum. The slides were washed
twice with 1xPBS, and twice with distilled water. 100
µl of goat anti-mouse secondary antibody (DyLight
488 fluorescent dye labeled, diluted 1:200 in 1%
BSA/1xPBS) was added to each slide and incubated
in a humidified chamber at room temperature for 1
hour under reduced light conditions. The slides were
washed twice with 1x PBS, and twice with double
distilled water and air dried in the dark under a laminar flow hood for 15 minutes and counterstained
with Vectashield with DAPI (Vector Labs). Images
were acquired by fluorescent microscopy as described
above. An internal validation study for the specificity
of this monoclonal antibody showed that it is able to
recognize Borrelia burgdorferi B31 and 297 strains but
not the reference strains of Borrelia afzelii and Borrelia
garinii, Escherichia coli or Treponema denticola (data not
shown).

DNA preparation from patient samples and
cultures
DNA was prepared from a portion of the initial
patient serum sample; the remainder of the serum
sample was used to seed the starter cultures. For
analysis at short term, cells were collected immediately from serum (1-4 ml) by centrifugation at 9600xg
for 10 minutes. For analysis at 8 or 16 weeks, cells
were collected from the long-term culture media (10
ml) or from the second collagen slide using a cell
scraper in 1 ml of the culture media, by centrifugation
at 9600xg for 10 minutes. DNA was extracted from
cell pellets using the QiaAmp DNA extraction kit
(Qiagen) according to the manufacturer’s instructions.
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Samples were eluted twice from the QiaAmp column
with 50 µl QiaAmp elution buffer, pooled and stored
at -20oC until analysis.

PCR reactions
Each positive culture sample was tested by PCR
using primers designed to amplify Borrelia 16S ribosomal RNA small subunit or CTP synthase genes. The
16S rRNA gene was amplified in a single reaction
using primers F: 5’- CCTGGCTTAGAACTAACG-3’;
R: 5’-CCTACAAAGCTTATTCCTCAT-3’ in a 50 µl
reaction containing HotStarTaq buffer (Qiagen) 1.5
mM MgCl2, 25 pmoles of each primer, and 2.5 units of
HotStarTaq DNA polymerase (Qiagen). Reaction
conditions were an initial denaturation at 94oC for 15
minutes, followed by 40 cycles of 94oC/30s, 50oC/30s,
72oC/1 min. then a final extension at 72oC/5min.
CTP synthase sequences were amplified in
nested reactions as described previously by Margos G
et al [35]. First round primers were F:
5’-ATTGCAAGTTCTGAGAATA-3’
and
R:
5’-CAAACATTACGAGCAAATTC-3’ in a 25 µl reaction with HotStarTaq buffer (Qiagen), 25 pmoles of
each primer, MgCl2 adjusted to 2.5 mM, and 1.5 units
HotStarTaq. Reaction conditions were an initial denaturation at 94oC for 15 minutes, followed by
94oC/30s, a 55oC step down from to 48oC decreasing
1C per cycle, followed by 30 cycles of 94oC/30s,
48oC/30s, 72oC/30s and a final extension at
72oC/5min. The nested reaction primers were F: 5’GATATGGAAAATATTTTATTTATTG -3’ and R:
5’-AAACCAAGACAAATTCCAAG -3’ in a 50 µl reaction containing 25 pmoles of each primer, 2.5 mM
MgCl2, 1.5 units HotStarTaq. Reaction conditions
were an initial denaturation at 94oC for 15 minutes,
followed by 35 cycles of 94oC/30s, 50oC/30s,
72oC/30s and a final extension at 72oC/5min. The
PCR products were analyzed by standard agarose
gel-electrophoresis.

Sequencing and sequence analyses
PCR products were purified using the QIAquick
PCR purification kit (Qiagen) according to the manufacturer’s instructions. Samples were eluted twice in
30 µl, and the eluates from each sample were pooled
and sequenced in both directions using the primers
that generated the products. Sequencing reactions
were performed by Eurofins/MGW/Operon (Huntsville, AL). Sequence alignment and neighbor-joining
phylogenetic analyses were conducted using MEGA
version 5 [36]. Tree support was evaluated by bootstrapping with 500 replications.

http://www.medsci.org
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Nucleotide sequence accession numbers
Nucleotide sequences for CTP synthase locus for
51 isolates have been deposited in GenBank
(http://www.ncbi.nlm.nih.gov) with the following
sequential accession numbers: JX867374 through
JX867424.

Statistical analyses
Statistical analyses were performed using modified Wald method with a 95% confidence interval as
well as the two-sample paired t-test utilized using
NCSS statistical software (NCSS LLC, Kaysville, UT).

Results
Optimization of BSK-H media
Standard BSK-H medium is the best available
medium to cultivate Borrelia. We first attempted to
improve the medium by testing a range of constituents including additional serum, reducing agents, and
various antibiotics. Bb strains B31 and 297 were cultured in BSK-H medium containing different amounts
of rabbit serum (6%, 12% or 20%), and the culture was
propagated at 34 °C with 5% CO2 and 100% humidity.
The culture was examined for spirochete growth by
dark field microscopy on day 6. While all three serum
concentrations supported spirochete growth, culturing spirochetes in 12% rabbit serum yielded approximately 25% more spirochetes for both strains (Figure
1, Panel A, p=0.008).
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Dithiothreitol (DTT) is a reducing agent that has
previously been found to improve the growth of Borrelia in vitro [37]. Bb B31 and 297 strains were cultured
in BSK-H medium with 12% rabbit serum and either
0. 145 µg/ml or 100 µg/ml DTT. The spirochete cultures were incubated in a CO2 incubator at 34°C with
5% CO2 and 100% humidity for 6 days. Compared to
control or low dose DTT (0.145 µg/ml), 100 µg/ml of
DTT nearly doubled the spirochete yield (p=0.0002)
for both strains (Figure 1, Panel B).
Antibiotics are commonly added to cultures to
suppress the overgrowth of other organisms. To test
the effect of this on Borrelia cultures, Bb B31 and 297
strains were cultivated in BSK-H medium containing
12% rabbit serum, 100 µg/ml DTT and one of the following antibiotics: 0.5 µg/ml rifampicin, a 5 µg rifampicin disc (resulting in final concentration of 0.4
µg/ml), 50 µg/ml rifampicin, or phosphomycin. The
spirochetes were incubated in a CO2 incubator at 34°C
with 5% CO2 and 100% humidity for 6 days and
growth was evaluated by dark field microscopy.
Culturing spirochetes with either 0.4 or 0.5 µg/ml
rifampicin had no effect on spirochete yield, while
using a higher concentration (50 µg/ml) of rifampicin
significantly decreased the spirochete yield (Figure 1,
Panel C, p=0.001). Similarly when three different
concentrations of phosphomycin were included in the
culture medium, spirochete yield was significantly
reduced (data not shown). Therefore we did not include this antibiotic in subsequent experiments.

Figure 1. shows the effect of different concentrations of rabbit serum (Panel A), DTT (Panel B) and antibiotic concentrations (Panel C)
on the growth of Borrelia burgdorferi B31 strains. The cells were cultured for 6 days with different concentration of rabbit serum, DTT and
antibiotics as depicted in the Figure and cellular growth was evaluated by direct cell counting of motile spirochetes using dark field
microscopy. Each set of data represents three independent experiments (mean ± SD). Statistical significance was determined using
two-sample paired t-test. The data *p-values <0.05 indicates statistical significance as related to control.

http://www.medsci.org
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Use of rifampicin alone (0.5 µg/ml or a 5 µg disc)
in the culture prevented contamination in 120 of 122
cases. Thus we utilized BSK-H medium with 12%
normal rabbit serum, 100 µg/ml DTT, and either 0.4
or 0.5 µg/ml rifampicin in our subsequent cultures
and this will be referred to as modified BSK-H
(mBSK-H) medium.

cultures grew exclusively in the additive-free tube
and to ensure no loss of spirochetes due to transport
tube preference, further experiments utilized both
transport
systems.
Blood
collected
in
EDTA-containing tubes gave the lowest yield of 1/50
and thus was abandoned from further use.

Initial sample collection

Most previous studies have cultured Borrelia in
15 ml glass tubes which were tightly closed and
placed in a standard 33-35 degree Celsius incubator
[1], [27]. More recently, a smaller 2 ml polypropylene
tube has been found to increase the yield [38]. Therefore, the two different tubes were compared. Serum
collected from 50 seropositive Lyme disease patients
was inoculated into the two different tubes and cultured with mBSK-H media. Cultures from 27 of these
50 patients were positive for Borrelia by 6 days. Of the
27 positive cultures, 5 were positive in both culture
environments while 17 were positive in the 15 ml
glass tube only, and 5 samples grew exclusively in the
2 ml tube system as outlined in Table 1. Therefore, to
maximize yield, both 15 ml and 2 ml tube formats
were included in the final protocol.
Figure 2 is a representative picture of three successful cultures from seropositive Lyme disease patients after 6 days of culturing. PCR and direct sequencing of the 16S rDNA amplicon further confirmed the presence of Borrelia spirochetes.

50 seropositive Lyme disease patients were
studied to test variables in blood collection. Specifically, the use of plasma or serum from the peripheral
blood with or without the addition of BSK-H media at
the time of collection was examined. Peripheral blood
samples were collected in purple-top Vacutainer
tubes (EDTA additive, resulting in a plasma sample),
in red-top Vacutainer tubes (no additive, resulting in a
serum sample), and in 15 ml sterile Falcon tubes with
5 ml of BSK-H medium and were shipped overnight
to set up the culture. A positive culture was determined by dark field microscopy and immunocytochemical methods. Collectively, 27 positive cultures
were obtained from either the additive-free or BSK-H
containing tubes. The tube with whole blood plus
BSK-H medium provided the best environment for
the 24h transit as this method produced the highest
number of positive cultures (24/50, 48%). However,
the additive-free tubes (serum) provided a sufficient
transit environment for 11 samples (22%) with 8 samples growing from both tube formats (16%). Because 3

Testing different culture tubes

Figure 2. shows immunocytochemical images of representative cultures from three seropositive Lyme disease patients (Panel A, B and
C). The serum samples were collected and cultured for 6 days and immunostained with polyclonal fluorescent antibodies against Borrelia
burgdorferi as described in Materials and Methods. Magnification 400x.

http://www.medsci.org
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Establishment of Long-term culture environment
Each of the 50 cultures from seropositive Lyme
patients described above was continued by adding
fresh mBSK-H media and incubating them for additional time. However, after 8-10 days, further growth
of the spiral form ceased and spirochetes tended to
convert into different morphological forms (data not
shown) as described previously [39]-[42]. Multiple
attempts to revert them back to spiral form were unsuccessful regardless of the use of several different
media such as the original BSK-II medium [27], modified Kelly medium (MKP medium) [43], MPM medium [44], and BSK modified medium [45]. In addition, several solid BSK-based media [46] and
PMR-agar media [43] were similarly tested but likewise were not capable of maintaining spirochetal
growth.
We thus explored other variables: media and
tubes (5-13 ml in 15 ml glass tubes and 1ml-1.8ml in
the 2 ml small cryo tubes), other tube sizes (5ml and
10ml tubes), tube material (glass and plastic), culture
temperature (28-37 degree Celsius), CO2 concentration (0-5%), and O2 concentration using BD BBL
Gaspak systems (anaerobic and semi-anaerobic systems). Despite altering these culture conditions, there
was no improvement in growth.
In summary, while the addition of serum, a reducing agent and rifampicin had a positive effect on
the short-term Borrelia cultures both by increasing
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yield and rate of initial growth, additional parameters
needed to be optimized to improve long-term Borrelia
cultures.
In infected mammals, Borrelia are most often
found to be sequestered in collagen and especially
collagen type I [47] [48]. A collagen matrix has been
shown to support growth of Borrelia burgdorferi B31
and 297 strains in vitro [38] [49]. To study this further
we initiated an experiment in which different
amounts of Bb B31 cells (1, 10, 100, 1000) were spiked
into 10 ml of whole peripheral blood from healthy
donors and after a short term culture of 6 days in
mBSK-H the culture was transferred to long-term
cultures set up in Coplin jars with collagen-coated
slides in a total of 45 ml of mBSK-H media. After 14
days, an accumulation of Borrelia growth was observed on all collagen coated slides. To evaluate this
growth, a slide was removed from the Coplin jar and
stained with the BacLight Live/Dead staining kit (see
Materials and Methods). Figure 3A demonstrates a
large thriving colony of attached spirochetes, with a
very low proportion of non-viable spirochetes. Blood
samples that were not spiked with Borrelia cells did
not produce any spirochetes on the collagen-coated
slides (Figure 3B). These data confirm that under favorable conditions human blood containing as few as
one Borrelia B31 spirochete can be cultured in mBSK-H
with a collagen source, which supports the original
hypothesis that a matrix-supported environment is
beneficial for their growth.

Figure 3. shows BacLight DEAD/LIVE stained Borrelia burgdorferi on collagen-coated slides. For this experiment, 1 (Panel A) or 0 (Panel
B) bacterial cell was spiked into 10 ml of human blood and cultured in a Coplin jar with collagen-coated slides and mBSK-H culture medium
for 4 weeks and stained with Baclight DEAD/LIVE stains as described in Materials and Methods. Green staining=live cells, red staining=dead cells. Magnification: 200X.
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Figure 4. shows the immunocytochemical images of one representative clinical sample of a Lyme disease patient whose diagnosis was
supported by the 2-tiered serological method that follows the CDC surveillance testing guidelines. The serum sample was cultured with
our culture method for 8 weeks and the obtained collagen-coated slides were immunostained with polyclonal fluorescent antibodies
against Borrelia burgdorferi. Panels A-D represent 4 different fields of one collagen-coated slide showing individual spirochetes and small and
large spirochetal aggregates that stained positively for Borrelia burgdorferi antigen (green staining). Magnification: 200X.

To explore whether a collagen source would be
beneficial to growth of wild type Borrelia, 10 cultures
from serologically positive Lyme disease patients that
were negative at day 6 in culture were converted into
long-term cultures. After 4 and 8 weeks spirochetal
growth was identified in four of these ten cultures and
those spirochetal structures stained positively with
the polyclonal anti-Borrelia antibody. Examination of
the slides showed individual spirochetes as well as
small and large aggregates of spirochetes. Figure 4
shows representative fields of one collagen-coated
slide from one of the positive samples (Panel A-D). To
test whether a long-term culture can be set up directly, serum from seropositive Lyme disease patients
was seeded into 45 ml of mBSK-H media in a Coplin
jar containing two collagen slides. All attempts to establish a long-term Borrelia culture from patient sera
in this manner were not successful (data not shown).

This confirmed the need to seed a long-term culture
from a short-term starter culture.

Validation study in 72 CDC-positive Lyme
disease patients
This study enrolled 72 Lyme disease patients
whose diagnosis was confirmed by a typical clinical
history and a positive result on a 2-tiered serological
test following CDC testing guidelines. It was required
that each donor had not been exposed to antibiotics
for a minimum of 4 weeks prior to blood draw as
recommended in previous studies [33] [34].
Short-term cultures were established in mBSK-H as
described and after six days these cultures were used
to seed collagen-supported long-term cultures. The
details of the procedure are summarized in Figure 5.
Analysis on day 6 using polyclonal anti-Borrelia antibody revealed that 34 of the 72 (47%) cultures showed
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growth (Figure 6). Long-term cultures were then begun from all the patient samples at day 6 and were
analyzed again at 8 and 16 weeks (Figure 6). An additional 26 samples became positive for Borrelia at 8
weeks for a total of 60 of 72 (83%) and at 16 weeks an
additional 8 samples became positive for Borrelia 68 of
72 (94%). All samples that were positive by polyclonal
staining (representative images in Figure 7) also
stained positively with the monoclonal antibody
(representative images in Figure 8).
Borrelia-specific PCR products were amplified
from each of the antibody-positive samples confirming that each sample contained Borrelia. Sequence
analysis at the 16S rRNA or CTP synthase locus or
both was performed and confirmed that each PCR
product was Borrelia DNA. Significant sequence variations were identified among 51 samples sequenced at
the CTP synthase gene locus indicating that samples
were derived from independent sources and not from
laboratory contamination. The percentage of the sequence identity of the clinical isolates to the Borrelia
burgdorferi B31/N40 strains reference sequences (accession #AE000783 and #CP002228 respectively)
ranged from 92%-100%. The numbers of polymorphic
sites found in the clinical isolates for CTP synthase
loci and the percentage of identity to Borrelia burgdorferi B31 sequence summarized in Table 3.
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Figure 5. outlines the individual steps of the short and long-term
culture procedures. ICC=immunocytochemistry.

Figure 6. summarizes the percentage of the successful Borrelia burgdorferi cultures of the clinical samples from the 72 Lyme disease
patients whose diagnosis was supported by the 2-tiered serological method that follows the CDC surveillance testing guidelines. The
samples were cultured with our novel method for 6 days, 8 weeks and 16 weeks and the cultures were confirmed to be Borrelia burgdorferi
species by immunocytochemical and PCR methodologies (see Material and Methods). The figure shows that 34 of the 72 cultures were
positive after 6-days of culturing (47% with a 95% confidence interval of 36%-58%) an additional 26 samples showed spirochetal presence
at 8 weeks of culture (83% with a 95% confidence interval of 72%-92%). At 16 weeks an additional 8 samples became positive for spirochetal growth (94% with a 95% confidence interval of 86%-97%). The confidence interval values are depicted by bars.
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Figure 7. demonstrates immunocytochemical images of nine representative positive clinical samples of the 72 Lyme disease patients
whose diagnosis was supported by the 2-tiered serological method that follows the CDC surveillance testing guidelines. The samples were
cultured with our novel method for 8 weeks and immunostained with polyclonal fluorescent antibodies against Borrelia burgdorferi (green
staining). Panels A-I: Nine representative samples, 400x.
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Figure 8. demonstrates immunocytochemical images of nine representative clinical samples of 72 Lyme disease patients whose diagnosis
was supported by the 2-tiered serological method that follows the CDC surveillance testing guidelines. The samples were cultured with
our novel method for 8 weeks and immunostained with monoclonal fluorescent antibodies against Borrelia burgdorferi (green staining).
Panels A-I: Nine representative samples, 400x.
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Table 3. Summary of the numbers of the polymorphic sites for
the CTP synthase locus and the % of identity to Borrelia burgdorferi
B31 strain of the 51 clinical isolates obtained from our validation
study.
Number Genbank Accession Numbers of # of Polyof Iso- the Clinical Isolates
morphic
lates
Sites

% of
Identity
to Borrelia
burgdorferi
B31

10

JX867374, JX867377, JX867381 –
92, JX867395 – 97, JX867399,
JX867400 and JX867405

0

100%

1

JX867419

2

99%

1

JX867376

21

97%

1

JX867393

39

93%

21

JX867375, JX867401 – 04,
JX867406 – 16, JX867418 and
JX867420 – 23

41

93%

4

JX867378 – JX867380 and
JX867417

42

93%

1

JX867394

43

93%

1

JX867398

49

92%

1

JX867424

51

92%

Sequence alignment (CLUSTELW) and neighbor-joining phylogenetic analysis were conducted on
a 600 bp alignment of the CTP synthase gene of Bb
clinical isolates obtained from the validation study
using MEGA 5 Evolutionary Genetics Analysis program [36]. Tree support was evaluated by bootstrapping with 500 replications. Figure 9 shows the result
of the analyses indicating of several sequence clusters
for the CTP synthase genes derived from the DNA
samples of the 51 clinical isolates. The resulting CTP
synthase sequences were submitted to the NCBI national genome database (accession numbers are listed
in Materials and Methods). Limited sequence variation was also noted at the well-conserved 16S rDNA
site (data not shown).
To ensure the specificity of this culture method
and any subsequent detection system, serum was
collected from 48 healthy controls with no history of
tick bites or of Lyme disease and was processed using
the above short-term and long-term culture methods.
All 48 negative control samples were negative by dark
field microscopy and by anti-Borrelia monoclonal and
polyclonal antibody staining at all time points we
examined (6 days, 8 weeks, and 16 weeks; 100%).
Figure 9. shows a neighbor-joining phylogenetic analysis of 600 bp
alignment of the CTP synthase gene (pyrG) of the 51 Borrelia clinical
isolates obtained from our validation study using MEGA 5 Evolutionary Genetics Analysis program [36]. Alphanumeric codes represent GenBank (NCBI) ID numbers. Nucleotide sequences for CTP
synthase locus for 51 clinical isolates have the following sequential
accession numbers: JX867374 through JX867424. Numbers at nodes
indicate bootstrap support values (500 replicates).
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Discussion
Here we report the development and evaluation
of an improved method to culture Borrelia spirochetes
from peripheral blood of confirmed Lyme disease
patients. Results from this study showed that by optimizing collection and transport conditions, media
and growth environment, and the development of a
long-term culture method together provided improved growth conditions for Borrelia. This is demonstrated by a 94% detection rate for Borrelia burgdorferi
from sera of Lyme disease patients whose diagnoses
were confirmed under the CDC surveillance testing
guidelines. We have also found significant sequence
variation in these Borrelia samples which further
documents that the Borrelia grown in this culture system were not derived from laboratory contamination.
The negative results from sera from healthy controls
also argue against laboratory contamination as being
the source of the positive cultures and further confirm
the specificity of the test.
The maximum success rate for Borrelia blood
cultures as outlined in recent publications is in the
40-44% range after 8-12 weeks of culturing [10] [30]
[50]. By refining our collection and short-term cultivation methods we were able to get similar results
after just six days in culture. The highest rate of Borrelia growth previously reported from clinical samples
(up to 88%) involved cultures of skin, a tissue abundant in collagen [1] [2]. Such studies revealed a
maximal success rate similar to what we achieved in
our long term, collagen supported in vitro culture
system (84% at 8 weeks and 94% at 16 weeks).
Unlike what has been reported by others, [50] we
found poor results when blood specimens were collected in tubes containing EDTA. We found that the
addition of BSK-H medium to the whole blood sample at the time of collection increased spirochete yield.
As previously reported [44], we also noted that allowing the serum to separate, especially when mixed
with BSK-H media, for up to 24 hours from the time of
the blood draw improved the culture success rate. The
BSK-H medium appeared to stabilize and even draw
out the spirochetes from the cellular fraction. Presence
of N-acetyl glucosamine (NAG) in the BSK-H medium, a known chemoattractant for Borrelia [51], may
facilitate this separation and support the spirochetes
during transport. Presumably, these freely suspended
Borrelia were better able to be cultivated. Interestingly,
there was a subset of clinical samples that grew better
in the collection tubes without additional BSK media.
Because of this observation, we utilized both methods
in our experiments to ensure maximal yield.
BSK-H has been the preferred media for isolating
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and cultivating spirochetes from human clinical samples [1] [27]. We made four changes that include: 1.
Higher concentration of rabbit serum (12% instead of
6%) incorporating the observation that cultivation of
other Borrelia strains such as Borrelia hermsii requires a
higher percentage of serum [52]. 2. Based on the previous observation that DTT added to BSK-H media
helped to isolate Borrelia spirochetes from Ixodes ticks
[37], by testing different concentrations of DTT we
determined that a high concentration of DTT (100
µg/ml) enhanced the growth of Borrelia in our cultures. 3. Since Borrelia species are known to be microaerophilic, meaning that while some oxygen is needed
for viability, high oxygen concentrations can be inhibitory [53], conditions that limit but not eliminate
oxygen, such as partially shut lids, nearly full tubes
and use of a CO2 incubator facilitated growth. 4. Low
concentration of rifampicin (0.4-0.5 µg/ml) prevented
secondary bacterial overgrowth in all but 2 out of 122
cultures used in this study. In addition, the use of two
different types and sizes of tubes in the starter culture
improved outcome.
The long-term culture system provided the
greatest advantage in achieving a higher success rate.
It was found that modified BSK-H media did not
provide an efficient in vitro culture environment after
8-10 days. We thus investigated whether matrix protein as a solid support may provide a desirable environment for growth of Borrelia. [48]-[49]. Several matrix proteins were tested such as fibronectin, laminin
and hyaluronan, but collagen gave the best results,
consistent with previously published data [38] [54].
Interestingly, collagen is present both in skin biopsies
and in the novel long-term culture presented here and
may be a common reason for their growth advantage
over other cultures.
The identity of the spirochetes was confirmed in
all of the 68 culture-positive, CDC-positive patients
enrolled in the validation study by staining positively
with Bb-specific monoclonal and polyclonal immunostains. Additionally, further confirmation of the
presence of Borrelia burgdorferi in these samples was
accomplished by testing all clinical isolates with DNA
PCR and then directly sequencing the DNA products.
Again, in all cases, results were consistent with Borrelia burgdorferi.
Several measures were employed to rule out the
possibility of false positives. Blood from 48 negative
controls was cultivated using the above established
methods and none showed any growth. Meticulous
DNA analyses of the positive cultures including the
use of both negative and positive controls in each PCR
reaction did not reveal any evidence for contamination. To confirm that Borrelia isolates that were culhttp://www.medsci.org
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tured from the 72 CDC positive patients were unique
and to further prove that the PCR products were not
from an environmental contaminant, PCR products
were directly sequenced at either the 16S rRNA or the
CTP synthase locus or both. The results confirmed
that the sequences from each positive culture sample
were derived from Borrelia. Sequence analysis within
the amplified region of 16S rRNA gene showed only
limited variation that is likely due to the highly conserved nature of 16S rRNA gene [55]. However,
abundant sequence variations were noted at the CTP
synthase locus from the positive cultures, indicating
that the clinical isolates are unique and derived from
wild-type Borrelia and not from a laboratory contaminant. The PCR and sequencing results were included
in this study to further validate the polyclonal and
monoclonal antibody assays used for the development of this Borrelia culture.
In summary, this report provides evidence for
the value of a novel method for culturing Borrelia from
human serum samples. The inclusion of key components such as modified culture media plus a unique
culture environment has resulted in an improvement
in the ability to cultivate this organism. This new
culture method directly addresses the issue of the low
numbers of Borrelia in clinical samples by amplifying
their quantity through long term culture in which
Borrelia were able to thrive for as long as eight months
(data not shown). The versatility of this method allows for samples to be harvested from the culture at
any point in time for further study, and it also serves
as a source of Borrelia for a variety of direct detection
techniques as well as for additional research. Finally,
this unique culture method could play an important
role in providing useful diagnostic information for
select Lyme disease patients who might have tested
negatively by other methods.
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